NBCRI has donated €1 million to the development of the Translational Research Facility at NUI Galway through Galway University Foundation.  

The Translational Research Facility at NUI Galway is being developed on the grounds of University Hospital Galway adjacent to the Clinical Sciences Institute. It will house ten principal investigators and one hundred and twenty researchers across a broad range of disciplines in cancer biology as well as other key research programmes in clinical disciplines.

The capacity for this space to be flexible and adaptable to different research needs means that there will be a continual flow of research programmes throughout its lifetime. This will be achieved by creating open-plan wet laboratory space, with an adjoining open plan write-up area, allowing research groups to expand and contract as their requirements change. The ten offices for principal investigators together with support facilities such as tissue culture and microscopy will be situated around the open plan area. The design of the building will, because of its open plan nature, help to facilitate the growth of multidisciplinary approaches to clinical problems.

Professor of Surgery at NUI Galway Michael Kerin: “The NBCRI has an extraordinary track record in funding breast cancer research since its establishment in 1991.  This latest gift will enhance the ability of the University to be internationally competitive and will ensure that the NBCRI has a footprint in the exciting Sate of the Art Translational Research Facility.  The infrastructure here will now be on a par with the world’s great Research Facilities and will enhance clinical developments and translational science for the West of Ireland’s population.” 

Medical Research at NUI Galway

NUI Galway is continually responding to the needs of the transforming healthcare service through aggressing research programmes and state of the art capital developments. The University’s vision in developing research Institutes and programmes in selected areas where we have a critical mass of experience and are recognised internationally has resulted in the development of many renowned research institutes such as the Regenerative Medicine Institute and the National Centre for Biomedical Engineering Science.

Interdisciplinary team-based research in regenerative medicine, cancer biology and therapeutics, biomedical engineering, glycoscience and neuroscience is focused on developing innovative diagnostic and therapeutic solutions to medical challenges including cardiovascular disease, orthopaedics, neurological disorders and cancer.

President of NUI Galway, Dr Jim Browne, said: “NUI Galway is very pleased to accept this generous donation towards the development of our Translational Research Facility.  This new facility will allow our researchers to ‘translate’ their work into practical strategies which will help patients and those facing currently intractable health problems.  The cutting edge work being done by Galway scientists and clinicians will be brought from ‘bench to bedside’ in the new Translational Research Facility.  On behalf of NUI Galway I would like to sincerely thank the NBCRI, who do such sterling work to raise awareness of breast cancer.  Their generous support will enable cancer sufferers to benefit from innovative treatments to address their health concerns in the future.” 

NCBRI

The National Breast Cancer Research Institute (NBCRI) is a voluntary based charity located at the Clinical Science Institute, University College Hospital, Galway. Launched in 1991, the key objective of the National Breast Cancer Research Institute is to conduct relevant, ethical research into the biology of breast cancer, to determine the cause of this disease and improve the treatment for patients. The National Breast Cancer Research Institute also work to raise awareness of breast cancer and fundraise to provide improved breast cancer services for women throughout Ireland.

Up to 2000 new cases of breast cancer are diagnosed in Ireland each year. As yet breast cancer cannot be prevented, its incidence can only be reduced by early detection. The cause and mechanism of action of breast cancer remain unknown. Treatments are available for breast cancer but ongoing research is essential to ensure the optimal treatment for all patients, to reduce their side effects, improve their quality of life and, primarily, increase their chance of survival.

The research team at The National Breast Cancer Research Institute are currently investigating the presence of biological markers involved in the detection, development and spread of breast cancer. The NBCRI funds postdoctoral scientists and postgraduate researchers and provides financial support for the running of the research laboratory.

ENDS